Literature DB >> 9486753

Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

B C Herold1, L C Immergluck, M C Maranan, D S Lauderdale, R E Gaskin, S Boyle-Vavra, C D Leitch, R S Daum.   

Abstract

CONTEXT: Community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections in children have occurred primarily in individuals with recognized predisposing risks. Community-acquired MRSA infections in the absence of identified risk factors have been reported infrequently.
OBJECTIVES: To determine whether community-acquired MRSA infections in children with no identified predisposing risks are increasing and to define the spectrum of disease associated with MRSA isolation.
DESIGN: Retrospective review of medical records. PATIENTS: Hospitalized children with S aureus isolated between August 1988 and July 1990 (1988-1990) and between August 1993 and July 1995 (1993-1995).
SETTING: The University of Chicago Children's Hospital. MAIN OUTCOME MEASURES: Prevalence of community-acquired MRSA over time, infecting vs colonizing isolates, and risk factors for disease.
RESULTS: The number of children hospitalized with community-acquired MRSA disease increased from 8 in 1988-1990 to 35 in 1993-1995. Moreover, the prevalence of community-acquired MRSA without identified risk increased from 10 per 100000 admissions in 1988-1990 to 259 per 100000 admissions in 1993-1995 (P<.001), and a greater proportion of isolates produced clinical infection. The clinical syndromes associated with MRSA in children without identified risk were similar to those associated with community-acquired methicillin-susceptible S aureus. Notably, 7 (70%) of 10 community-acquired MRSA isolates obtained from children with an identified risk were nonsusceptible to at least 2 drugs, compared with only 6 (24%) of 25 isolates obtained from children without an identified risk (P=.02).
CONCLUSIONS: These findings demonstrate that the prevalence of community-acquired MRSA among children without identified risk factors is increasing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486753     DOI: 10.1001/jama.279.8.593

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  395 in total

1.  Diagnosis of MRSA with neural networks and logistic regression approach.

Authors:  J S Shang; Y S Lin; A M Goetz
Journal:  Health Care Manag Sci       Date:  2000-09

2.  Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeast Queensland, Australia.

Authors:  G R Nimmo; J Schooneveldt; G O'Kane; B McCall; A Vickery
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

3.  Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains.

Authors:  Xiao Xue Ma; Teruyo Ito; Chuntima Tiensasitorn; Mantana Jamklang; Piriyaporn Chongtrakool; Susan Boyle-Vavra; Robert S Daum; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

4.  Recognition of two groups of methicillin-resistant Staphylococcus aureus strains based on epidemiology, antimicrobial susceptibility, hypervariable-region type, and ribotype in Finland.

Authors:  S Salmenlinna; J Vuopio-Varkila
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

5.  Swine exposure and methicillin-resistant Staphylococcus aureus infection among hospitalized patients with skin and soft tissue infections in Illinois: A ZIP code-level analysis.

Authors:  Glennon A Beresin; J Michael Wright; Glenn E Rice; Jyotsna S Jagai
Journal:  Environ Res       Date:  2017-07-31       Impact factor: 6.498

6.  Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus.

Authors:  W H Zhao; Z Q Hu; S Okubo; Y Hara; T Shimamura
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

7.  New chromogenic identification and detection of Staphylococcus aureus and methicillin-resistant S. aureus.

Authors:  J Merlino; M Leroi; R Bradbury; D Veal; C Harbour
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

8.  Nosocomial infections in ambulances and effectiveness of ambulance fumigation techniques in Saudi Arabia. Phase I study.

Authors:  Daifallah Alrazeeni; Mohammed S Al Sufi
Journal:  Saudi Med J       Date:  2014-11       Impact factor: 1.484

9.  Epicutaneous model of community-acquired Staphylococcus aureus skin infections.

Authors:  Ranjani Prabhakara; Oded Foreman; Roberto De Pascalis; Gloria M Lee; Roger D Plaut; Stanley Y Kim; Scott Stibitz; Karen L Elkins; Tod J Merkel
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

10.  Methicillin-Resistant Staphylococcus aureus: The Effects Are More Than Skin Deep.

Authors:  Carol E Muenks; Whitney C Sewell; Patrick G Hogan; Ryley M Thompson; David G Ross; Jeffrey W Wang; John J Morelli; Sarah J Gehlert; Stephanie A Fritz
Journal:  J Pediatr       Date:  2018-05-11       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.